Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.1 USD | +0.29% | -4.49% | +3.48% |
05:26pm | BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating | MT |
02:52pm | Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.48% | 283B | |
+26.07% | 661B | |
+26.74% | 566B | |
-6.73% | 352B | |
+19.43% | 332B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.32% | 145B | |
-10.65% | 144B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Issues Q3 Adjusted Earnings Guidance, Updates 2022 EPS Outlook